Similar articles

• Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

  Ruiz J. Ruiz J. J Antimicrob Chemother. 2003 May;51(5):1109-17. doi: 10.1093/jac/dkg222. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697644 Review.
• [Quinolone].

  Sato K, Tanaka M. Sato K, et al. Nihon Rinsho. 2003 Mar;61 Suppl 3:227-33. Nihon Rinsho. 2003. PMID: 12717976 Review. Japanese. No abstract available.
• Mechanisms of quinolone action and microbial response.

  Hawkey PM. Hawkey PM. J Antimicrob Chemother. 2003 May;51 Suppl 1:29-35. doi: 10.1093/jac/dkg207. J Antimicrob Chemother. 2003. PMID: 12702701 Review.
• Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.

  Okumura R, Hirata T, Onodera Y, Hoshino K, Otani T, Yamamoto T. Okumura R, et al. J Antimicrob Chemother. 2008 Jul;62(1):98-104. doi: 10.1093/jac/dkn136. Epub 2008 Apr 4. J Antimicrob Chemother. 2008. PMID: 18390884
• Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.

  Yun HJ, Min YH, Jo YW, Shim MJ, Choi EC. Yun HJ, et al. Int J Antimicrob Agents. 2005 Apr;25(4):334-7. doi: 10.1016/j.ijantimicag.2004.11.013. Int J Antimicrob Agents. 2005. PMID: 15784314